Literature DB >> 15757547

[Research advancement of endogenous angiogenesis inhibitors].

Jiang-Xue Wu1, Ben-Ling Xu, Wen-Lin Huang.   

Abstract

Angiogenesis is required for invasive tumor growth and metastasis. Inhibition of angiogenesis is considered to be a promising approach of antitumor therapy. Recently, many endogenous angiogenesis inhibitors have been discovered, some of them are currently in various stages of clinical trials. This review focused on the structure, function, and mechanism of endogenous angiogenesis inhibitors, and their potential in treating tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757547

Source DB:  PubMed          Journal:  Ai Zheng


  1 in total

1.  Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.

Authors:  Li-xia Li; Yan-ling Zhang; Ling Zhou; Miao-la Ke; Jie-min Chen; Xiang Fu; Chun-ling Ye; Jiang-xue Wu; Ran-yi Liu; Wenlin Huang
Journal:  J Transl Med       Date:  2013-10-14       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.